1,829
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Nuts consumption and hypertension risks in children: a mediating role of circulating lipid metabolites

, , , , , , & show all
Article: 2243056 | Received 08 Mar 2023, Accepted 26 Jul 2023, Published online: 08 Aug 2023

References

  • Song P, Zhang Y, Yu J, Zha M, Zhu Y, Rahimi K, Rudan I. Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr. 2019;173(12):1154–7. doi:10.1001/jamapediatrics.2019.3310.
  • Raitakari OT, Juonala M, Kahonen M, Taittonen L, Laitinen T, Maki-Torkko N, Jarvisalo MJ, Uhari M, Jokinen E, Ronnemaa T, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the cardiovascular risk in young Finns study. JAMA. 2003;290(17):2277–83. doi:10.1001/jama.290.17.2277.
  • Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa heart study. Am J Hypertens. 1995;8(7):657–65. doi:10.1016/0895-7061(95)00116-7.
  • Flynn JT. Childhood blood pressure matters. Hypertension. 2019;73(2):296–98. doi:10.1161/HYPERTENSIONAHA.118.12309.
  • Dauchet L, Kesse-Guyot E, Czernichow S, Bertrais S, Estaquio C, Peneau S, Vergnaud AC, Chat-Yung S, Castetbon K, Deschamps V, et al. Dietary patterns and blood pressure change over 5-y follow-up in the SU.VI.MAX cohort. Am J Clin Nutr. 2007;85(6):1650–56. doi:10.1093/ajcn/85.6.1650.
  • Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA. 2009;302(4):401–11. doi:10.1001/jama.2009.1060.
  • Williams PT, Fortmann SP, Terry RB, Garay SC, Vranizan KM, Ellsworth N, Wood PD. Associations of dietary fat, regional adiposity, and blood pressure in men. JAMA. 1987;257(23):3251–56. doi:10.1001/jama.1987.03390230087030.
  • Dehghan M, Mente A, Teo KK, Gao P, Sleight P, Dagenais G, Avezum A, Probstfield JL, Dans T, Yusuf S. Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries. Circulation. 2012;126(23):2705–12. doi:10.1161/CIRCULATIONAHA.112.103234.
  • Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American heart association. Hypertension. 2006;47(2):296–308. doi:10.1161/01.HYP.0000202568.01167.B6.
  • Gonzalez CA, Salas-Salvado J. The potential of nuts in the prevention of cancer. Br J Nutr. 2006;96(Suppl S2):S87–94. doi:10.1017/bjn20061868.
  • Kris-Etherton PM, Hu FB, Ros E, Sabate J. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr. 2008;138(9):1746S–51. doi:10.1093/jn/138.9.1746S.
  • Saldanha MH, Monnerat JAS, Costa NDS, Bento BT, Magliano DC, Pereira AD, Almeida PP, Lima GF, Ferreira DBFC, Stockler PMB, et al. Impact of Brazil nut (Bertholletia excelsa, H.B.K.) supplementation on body composition, blood pressure, and the vascular reactivity of Wistar rats when submitted to a hypersodium diet. J Am Nutr Assoc. 2022;41(6):559–68. doi:10.1080/07315724.2021.1925995.
  • Huguenin GV, Moreira AS, Siant’pierre TD, Goncalves RA, Rosa G, Oliveira GM, Luiz RR, Tibirica E. Effects of dietary supplementation with Brazil nuts on microvascular endothelial function in hypertensive and dyslipidemic patients: a randomized crossover placebo-controlled trial. Microcirculation. 2015;22(8):687–99. doi:10.1111/micc.12225.
  • Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, Tonstad S, Vatten LJ, Riboli E, Norat T. Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies. BMC Med. 2016;14(1):207. doi:10.1186/s12916-016-0730-3.
  • Pillai MV, Qureshi GD, Howells R, Narasimhachari N, Behm EG, Hazra TA. In vitro irradiation of blood platelets–effects on structure and function. Mil Med. 1985;150(9):496–98. doi:10.1093/milmed/150.9.496.
  • Mohan V, Gayathri R, Jaacks LM, Lakshmipriya N, Anjana RM, Spiegelman D, Jeevan RG, Balasubramaniam KK, Shobana S, Jayanthan M, et al. Cashew nut consumption increases HDL cholesterol and reduces systolic blood pressure in Asian Indians with type 2 diabetes: a 12-week randomized controlled trial. J Nutr. 2018;148(1):63–69. doi:10.1093/jn/nxx001.
  • Feng Y, Bi Y, Tang X, Zhang P, Tong J, Peng X, Tian J, Liang X. Protective effects of appropriate amount of nuts intake on childhood blood pressure level: a cross-sectional study. Front Med. 2021;8:793672. doi:10.3389/fmed.2021.793672.
  • de Souza RJ, Dehghan M, Mente A, Bangdiwala SI, Ahmed SH, Alhabib KF, Altuntas Y, Basiak-Rasala A, Dagenais GR, Diaz R, et al. Association of nut intake with risk factors, cardiovascular disease, and mortality in 16 countries from 5 continents: analysis from the Prospective Urban and Rural Epidemiology (PURE) study. Am J Clin Nutr. 2020;112(1):208–19. doi:10.1093/ajcn/nqaa108.
  • Del GLC, Falk MC, Feldman R, Lewis K, Mozaffarian D. Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: systematic review, meta-analysis, and dose-response of 61 controlled intervention trials. Am J Clin Nutr. 2015;102(6):1347–56. doi:10.3945/ajcn.115.110965.
  • Good D, Lavie CJ, Ventura HO. Dietary intake of nuts and cardiovascular prognosis. Ochsner J. 2009;9(1):32–36.
  • Kozlowski K, Szmigiel C, Konik R, Ostrowski A, Walecki J. Osteopetrosis with precocious manifestations. (Report of 3 familial and 1 sporadic case). Australas Radiol. 1972;16(3):311–15. doi:10.1111/j.1440-1673.1972.tb01371.x.
  • Rivas SIM, Sitina M, Stokin GB, Medina-Inojosa JR, Lopez-Jimenez F, Gonzalez-Rivas JP, Vinciguerra M. Lipidomic profiling identifies signatures of poor cardiovascular health. Metabolites. 2021;11(11):747. doi:10.3390/metabo11110747.
  • Guasch-Ferre M, Hernandez-Alonso P, Drouin-Chartier JP, Ruiz-Canela M, Razquin C, Toledo E, Li J, Dennis C, Wittenbecher C, Corella D, et al. Walnut consumption, plasma metabolomics, and risk of type 2 diabetes and cardiovascular disease. J Nutr. 2021;151(2):303–11. doi:10.1093/jn/nxaa374.
  • Syme C, Czajkowski S, Shin J, Abrahamowicz M, Leonard G, Perron M, Richer L, Veillette S, Gaudet D, Strug L, et al. Glycerophosphocholine metabolites and cardiovascular disease risk factors in adolescents: a cohort study. Circulation. 2016;134(21):1629–36. doi:10.1161/CIRCULATIONAHA.116.022993.
  • Liang X, Xiao L, Luo Y, Xu J. Prevalence and risk factors of childhood hypertension from birth through childhood: a retrospective cohort study. J Hum Hypertens. 2020;34(2):151–64. doi:10.1038/s41371-019-0282-z.
  • Liang X, Xiao L, Luo Y, Xu J. Prevalence and risk factors of childhood hypertension in urban-rural areas of China: a cross-sectional study. Int J Hypertens. 2020;2020:2374231. doi:10.1155/2020/2374231.
  • Chen J, Luo S, Liang X, Luo Y, Li R. The relationship between socioeconomic status and childhood overweight/obesity is linked through paternal obesity and dietary intake: a cross-sectional study in Chongqing, China. Environ Health Prev Med. 2021;26(1):56. doi:10.1186/s12199-021-00973-x.
  • Liang X, Chen M, Wang D, Wen J, Chen J. Vitamin a deficiency indicating as low expression of LRAT may be a novel biomarker of primary hypertension. Clin Exp Hypertens. 2021;43(2):151–63. doi:10.1080/10641963.2020.1833023.
  • Liang X, Chen J, An X, Liu F, Liang F, Tang X, Qu P. The impact of PM2.5 on children’s blood pressure growth curves: A prospective cohort study. Environ Int. 2022;158:107012. doi:10.1016/j.envint.2021.107012.
  • Liang X, Chen M, Qu P, Hao G, Huang Y, Chen J, Li T. The association of vitamin A and vitamin D with hypertension in children: a case-control study. Int J Hypertens. 2018;2018:1–8. doi:10.1155/2018/9295147.
  • Liang X, Tang X, Xi B, Qu P, Ren Y, Hao G. Abdominal obesity-related lipid metabolites may mediate the association between obesity and glucose dysregulation. Pediatr Res. 2023;93(1):183–88. doi:10.1038/s41390-022-02074-z.
  • Sun R, Lin Z, Wang X, Liu L, Huo M, Zhang R, Lin J, Xiao C, Li Y, Zhu W, et al. AADAC protects colorectal cancer liver colonization from ferroptosis through SLC7A11-dependent inhibition of lipid peroxidation. J Exp Clin Cancer Res. 2022;41(1):284. doi:10.1186/s13046-022-02493-0.
  • Sabate J, Wien M. Nuts, blood lipids and cardiovascular disease. Asia Pac J Clin Nutr. 2010;19(1):131–36.
  • Banel DK, Hu FB. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. Am J Clin Nutr. 2009;90(1):56–63. doi:10.3945/ajcn.2009.27457.
  • Ros E, Singh A, O’Keefe JH. Nuts: natural pleiotropic nutraceuticals. Nutrients. 2021;13(9):3269. doi:10.3390/nu13093269.
  • Guarneiri LL, Paton CM, Cooper JA. Pecan-Enriched diets alter cholesterol profiles and triglycerides in adults at risk for cardiovascular disease in a randomized, controlled trial. J Nutr. 2021;151(10):3091–101. doi:10.1093/jn/nxab248.
  • Michos ED, McEvoy JW, Blumenthal RS, Jarcho JA. Lipid management for the prevention of atherosclerotic cardiovascular disease. N Engl J Med. 2019;381(16):1557–67. doi:10.1056/NEJMra1806939.
  • Souza RG, Gomes AC, Naves MM, Mota JF. Nuts and legume seeds for cardiovascular risk reduction: scientific evidence and mechanisms of action. Nutr Rev. 2015;73(6):335–47. doi:10.1093/nutrit/nuu008.
  • Toledo E, Wang DD, Ruiz-Canela M, Clish CB, Razquin C, Zheng Y, Guasch-Ferre M, Hruby A, Corella D, Gomez-Gracia E, et al. Plasma lipidomic profiles and cardiovascular events in a randomized intervention trial with the Mediterranean diet. Am J Clin Nutr. 2017;106(4):973–83. doi:10.3945/ajcn.116.151159.
  • Koska J, Ozias MK, Deer J, Kurtz J, Salbe AD, Harman SM, Reaven PD. A human model of dietary saturated fatty acid induced insulin resistance. Metabolism. 2016;65(11):1621–28. doi:10.1016/j.metabol.2016.07.015.
  • Del GLC, Imamura F, Aslibekyan S, Marklund M, Virtanen JK, Wennberg M, Yakoob MY, Chiuve SE, Dela CL, Frazier-Wood AC, et al. Omega-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies. JAMA Intern Med. 2016;176(8):1155–66. doi:10.1001/jamainternmed.2016.2925.
  • Eshiginia S, Gapparov MM, Soto K. Influence of phospholipids on efficiency of dietary therapy and parameters of lipids metabolism in patients with hypertension. Vopr Pitan. 2005;74(5):28–31.
  • Kullenberg D, Taylor LA, Schneider M, Massing U. Health effects of dietary phospholipids. Lipids in health and disease. Lipids Health Dis. 2012;11(1):3. doi:10.1186/1476-511X-11-3.